Company / Debt per Share
Arcutis Biotherapeutics, Inc. Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.92
FY2025
5-year range
$0.92 / $3.59
FY2021-FY2025
Trend
-16.5%
vs FY2024
Sector context
#62 of 82
Health Care
What the data says
Arcutis Biotherapeutics, Inc.'s debt per share of $0.92 is lower than 76% of companies in the Health Care sector (FY2025). Debt per Share has declined for 3 consecutive years, from $3.59 in FY2022 to $0.92 in FY2025.
Based on SEC 10-K filings.
0.92 in FY2025 with a 3-year CAGR of -36.4%.
Improved from $2.91 to $0.92 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -36.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 82This company $0.92 Sector average $126.59
▼
-99.3% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s debt per share has declined for 3 consecutive years.
- In FY2025, debt per share decreased 16.5% year-over-year.
- Ranks #62 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.92 | -16.5% |
| FY2024 | $1.11 | -62.0% |
| FY2023 | $2.91 | -19.0% |
| FY2022 | $3.59 | +145.4% |
| FY2021 | $1.46 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026